Pre-order Enquiry
Request Free Sample
Global Myocarditis Treatment and Diagnosis Market Research Report 2022
SKU ID : QYR-21177678 | Publishing Date : 29-Jun-2022 | No. of pages : 86
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Myocarditis Treatment and Diagnosis Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myocarditis Treatment and Diagnosis Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Treatment
1.2.3 Diagnosis
1.3 Market by Application
1.3.1 Global Myocarditis Treatment and Diagnosis Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Acute Myocarditis
1.3.3 Chronic Myocarditis
1.3.4 Lymphocytic Myocarditis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Myocarditis Treatment and Diagnosis Market Perspective (2017-2028)
2.2 Myocarditis Treatment and Diagnosis Growth Trends by Region
2.2.1 Myocarditis Treatment and Diagnosis Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Myocarditis Treatment and Diagnosis Historic Market Size by Region (2017-2022)
2.2.3 Myocarditis Treatment and Diagnosis Forecasted Market Size by Region (2023-2028)
2.3 Myocarditis Treatment and Diagnosis Market Dynamics
2.3.1 Myocarditis Treatment and Diagnosis Industry Trends
2.3.2 Myocarditis Treatment and Diagnosis Market Drivers
2.3.3 Myocarditis Treatment and Diagnosis Market Challenges
2.3.4 Myocarditis Treatment and Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Myocarditis Treatment and Diagnosis Players by Revenue
3.1.1 Global Top Myocarditis Treatment and Diagnosis Players by Revenue (2017-2022)
3.1.2 Global Myocarditis Treatment and Diagnosis Revenue Market Share by Players (2017-2022)
3.2 Global Myocarditis Treatment and Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Myocarditis Treatment and Diagnosis Revenue
3.4 Global Myocarditis Treatment and Diagnosis Market Concentration Ratio
3.4.1 Global Myocarditis Treatment and Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myocarditis Treatment and Diagnosis Revenue in 2021
3.5 Myocarditis Treatment and Diagnosis Key Players Head office and Area Served
3.6 Key Players Myocarditis Treatment and Diagnosis Product Solution and Service
3.7 Date of Enter into Myocarditis Treatment and Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Myocarditis Treatment and Diagnosis Breakdown Data by Type
4.1 Global Myocarditis Treatment and Diagnosis Historic Market Size by Type (2017-2022)
4.2 Global Myocarditis Treatment and Diagnosis Forecasted Market Size by Type (2023-2028)
5 Myocarditis Treatment and Diagnosis Breakdown Data by Application
5.1 Global Myocarditis Treatment and Diagnosis Historic Market Size by Application (2017-2022)
5.2 Global Myocarditis Treatment and Diagnosis Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Myocarditis Treatment and Diagnosis Market Size (2017-2028)
6.2 North America Myocarditis Treatment and Diagnosis Market Size by Country (2017-2022)
6.3 North America Myocarditis Treatment and Diagnosis Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Myocarditis Treatment and Diagnosis Market Size (2017-2028)
7.2 Europe Myocarditis Treatment and Diagnosis Market Size by Country (2017-2022)
7.3 Europe Myocarditis Treatment and Diagnosis Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Myocarditis Treatment and Diagnosis Market Size (2017-2028)
8.2 Asia-Pacific Myocarditis Treatment and Diagnosis Market Size by Country (2017-2022)
8.3 Asia-Pacific Myocarditis Treatment and Diagnosis Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Myocarditis Treatment and Diagnosis Market Size (2017-2028)
9.2 Latin America Myocarditis Treatment and Diagnosis Market Size by Country (2017-2022)
9.3 Latin America Myocarditis Treatment and Diagnosis Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Myocarditis Treatment and Diagnosis Market Size (2017-2028)
10.2 Middle East & Africa Myocarditis Treatment and Diagnosis Market Size by Country (2017-2022)
10.3 Middle East & Africa Myocarditis Treatment and Diagnosis Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 F. Hoffmann-La Roche Ltd. Company Detail
11.1.2 F. Hoffmann-La Roche Ltd. Business Overview
11.1.3 F. Hoffmann-La Roche Ltd. Myocarditis Treatment and Diagnosis Introduction
11.1.4 F. Hoffmann-La Roche Ltd. Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022)
11.1.5 F. Hoffmann-La Roche Ltd. Recent Development
11.2 Mylan N.V.
11.2.1 Mylan N.V. Company Detail
11.2.2 Mylan N.V. Business Overview
11.2.3 Mylan N.V. Myocarditis Treatment and Diagnosis Introduction
11.2.4 Mylan N.V. Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022)
11.2.5 Mylan N.V. Recent Development
11.3 Teva Pharmaceutical Industries Ltd.
11.3.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.3.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.3.3 Teva Pharmaceutical Industries Ltd. Myocarditis Treatment and Diagnosis Introduction
11.3.4 Teva Pharmaceutical Industries Ltd. Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022)
11.3.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Detail
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Myocarditis Treatment and Diagnosis Introduction
11.4.4 Pfizer Inc. Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022)
11.4.5 Pfizer Inc. Recent Development
11.5 GlaxoSmithKline plc
11.5.1 GlaxoSmithKline plc Company Detail
11.5.2 GlaxoSmithKline plc Business Overview
11.5.3 GlaxoSmithKline plc Myocarditis Treatment and Diagnosis Introduction
11.5.4 GlaxoSmithKline plc Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022)
11.5.5 GlaxoSmithKline plc Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Detail
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Myocarditis Treatment and Diagnosis Introduction
11.6.4 Novartis AG Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022)
11.6.5 Novartis AG Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Myocarditis Treatment and Diagnosis Introduction
11.7.4 Johnson & Johnson Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022)
11.7.5 Johnson & Johnson Recent Development
11.8 Bayer AG
11.8.1 Bayer AG Company Detail
11.8.2 Bayer AG Business Overview
11.8.3 Bayer AG Myocarditis Treatment and Diagnosis Introduction
11.8.4 Bayer AG Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022)
11.8.5 Bayer AG Recent Development
11.9 Sun Pharmaceutical Industries Ltd.
11.9.1 Sun Pharmaceutical Industries Ltd. Company Detail
11.9.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.9.3 Sun Pharmaceutical Industries Ltd. Myocarditis Treatment and Diagnosis Introduction
11.9.4 Sun Pharmaceutical Industries Ltd. Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022)
11.9.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.10 Merck & Co., Inc.
11.10.1 Merck & Co., Inc. Company Detail
11.10.2 Merck & Co., Inc. Business Overview
11.10.3 Merck & Co., Inc. Myocarditis Treatment and Diagnosis Introduction
11.10.4 Merck & Co., Inc. Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022)
11.10.5 Merck & Co., Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Myocarditis Treatment and Diagnosis Market Research Report 2022
List of TablesTable 1. Global Myocarditis Treatment and Diagnosis Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Treatment
Table 3. Key Players of Diagnosis
Table 4. Global Myocarditis Treatment and Diagnosis Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Myocarditis Treatment and Diagnosis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Myocarditis Treatment and Diagnosis Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Myocarditis Treatment and Diagnosis Market Share by Region (2017-2022)
Table 8. Global Myocarditis Treatment and Diagnosis Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Myocarditis Treatment and Diagnosis Market Share by Region (2023-2028)
Table 10. Myocarditis Treatment and Diagnosis Market Trends
Table 11. Myocarditis Treatment and Diagnosis Market Drivers
Table 12. Myocarditis Treatment and Diagnosis Market Challenges
Table 13. Myocarditis Treatment and Diagnosis Market Restraints
Table 14. Global Myocarditis Treatment and Diagnosis Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Myocarditis Treatment and Diagnosis Market Share by Players (2017-2022)
Table 16. Global Top Myocarditis Treatment and Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myocarditis Treatment and Diagnosis as of 2021)
Table 17. Ranking of Global Top Myocarditis Treatment and Diagnosis Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Myocarditis Treatment and Diagnosis Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Myocarditis Treatment and Diagnosis Product Solution and Service
Table 21. Date of Enter into Myocarditis Treatment and Diagnosis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Myocarditis Treatment and Diagnosis Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Myocarditis Treatment and Diagnosis Revenue Market Share by Type (2017-2022)
Table 25. Global Myocarditis Treatment and Diagnosis Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Myocarditis Treatment and Diagnosis Revenue Market Share by Type (2023-2028)
Table 27. Global Myocarditis Treatment and Diagnosis Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Myocarditis Treatment and Diagnosis Revenue Market Share by Application (2017-2022)
Table 29. Global Myocarditis Treatment and Diagnosis Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Myocarditis Treatment and Diagnosis Revenue Market Share by Application (2023-2028)
Table 31. North America Myocarditis Treatment and Diagnosis Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Myocarditis Treatment and Diagnosis Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Myocarditis Treatment and Diagnosis Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Myocarditis Treatment and Diagnosis Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Myocarditis Treatment and Diagnosis Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Myocarditis Treatment and Diagnosis Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Myocarditis Treatment and Diagnosis Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Myocarditis Treatment and Diagnosis Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Myocarditis Treatment and Diagnosis Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Myocarditis Treatment and Diagnosis Market Size by Country (2023-2028) & (US$ Million)
Table 41. F. Hoffmann-La Roche Ltd. Company Detail
Table 42. F. Hoffmann-La Roche Ltd. Business Overview
Table 43. F. Hoffmann-La Roche Ltd. Myocarditis Treatment and Diagnosis Product
Table 44. F. Hoffmann-La Roche Ltd. Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022) & (US$ Million)
Table 45. F. Hoffmann-La Roche Ltd. Recent Development
Table 46. Mylan N.V. Company Detail
Table 47. Mylan N.V. Business Overview
Table 48. Mylan N.V. Myocarditis Treatment and Diagnosis Product
Table 49. Mylan N.V. Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022) & (US$ Million)
Table 50. Mylan N.V. Recent Development
Table 51. Teva Pharmaceutical Industries Ltd. Company Detail
Table 52. Teva Pharmaceutical Industries Ltd. Business Overview
Table 53. Teva Pharmaceutical Industries Ltd. Myocarditis Treatment and Diagnosis Product
Table 54. Teva Pharmaceutical Industries Ltd. Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022) & (US$ Million)
Table 55. Teva Pharmaceutical Industries Ltd. Recent Development
Table 56. Pfizer Inc. Company Detail
Table 57. Pfizer Inc. Business Overview
Table 58. Pfizer Inc. Myocarditis Treatment and Diagnosis Product
Table 59. Pfizer Inc. Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022) & (US$ Million)
Table 60. Pfizer Inc. Recent Development
Table 61. GlaxoSmithKline plc Company Detail
Table 62. GlaxoSmithKline plc Business Overview
Table 63. GlaxoSmithKline plc Myocarditis Treatment and Diagnosis Product
Table 64. GlaxoSmithKline plc Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022) & (US$ Million)
Table 65. GlaxoSmithKline plc Recent Development
Table 66. Novartis AG Company Detail
Table 67. Novartis AG Business Overview
Table 68. Novartis AG Myocarditis Treatment and Diagnosis Product
Table 69. Novartis AG Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022) & (US$ Million)
Table 70. Novartis AG Recent Development
Table 71. Johnson & Johnson Company Detail
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Myocarditis Treatment and Diagnosis Product
Table 74. Johnson & Johnson Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Bayer AG Company Detail
Table 77. Bayer AG Business Overview
Table 78. Bayer AG Myocarditis Treatment and Diagnosis Product
Table 79. Bayer AG Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022) & (US$ Million)
Table 80. Bayer AG Recent Development
Table 81. Sun Pharmaceutical Industries Ltd. Company Detail
Table 82. Sun Pharmaceutical Industries Ltd. Business Overview
Table 83. Sun Pharmaceutical Industries Ltd. Myocarditis Treatment and Diagnosis Product
Table 84. Sun Pharmaceutical Industries Ltd. Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022) & (US$ Million)
Table 85. Sun Pharmaceutical Industries Ltd. Recent Development
Table 86. Merck & Co., Inc. Company Detail
Table 87. Merck & Co., Inc. Business Overview
Table 88. Merck & Co., Inc. Myocarditis Treatment and Diagnosis Product
Table 89. Merck & Co., Inc. Revenue in Myocarditis Treatment and Diagnosis Business (2017-2022) & (US$ Million)
Table 90. Merck & Co., Inc. Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Myocarditis Treatment and Diagnosis Market Share by Type: 2021 VS 2028
Figure 2. Treatment Features
Figure 3. Diagnosis Features
Figure 4. Global Myocarditis Treatment and Diagnosis Market Share by Application in 2021 & 2028
Figure 5. Acute Myocarditis Case Studies
Figure 6. Chronic Myocarditis Case Studies
Figure 7. Lymphocytic Myocarditis Case Studies
Figure 8. Myocarditis Treatment and Diagnosis Report Years Considered
Figure 9. Global Myocarditis Treatment and Diagnosis Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Myocarditis Treatment and Diagnosis Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Myocarditis Treatment and Diagnosis Market Share by Region: 2021 VS 2028
Figure 12. Global Myocarditis Treatment and Diagnosis Market Share by Players in 2021
Figure 13. Global Top Myocarditis Treatment and Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myocarditis Treatment and Diagnosis as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Myocarditis Treatment and Diagnosis Revenue in 2021
Figure 15. North America Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Myocarditis Treatment and Diagnosis Market Share by Country (2017-2028)
Figure 17. United States Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Myocarditis Treatment and Diagnosis Market Share by Country (2017-2028)
Figure 21. Germany Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Myocarditis Treatment and Diagnosis Market Share by Region (2017-2028)
Figure 29. China Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Myocarditis Treatment and Diagnosis Market Share by Country (2017-2028)
Figure 37. Mexico Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Myocarditis Treatment and Diagnosis Market Share by Country (2017-2028)
Figure 41. Turkey Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Myocarditis Treatment and Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Myocarditis Treatment and Diagnosis Business (2017-2022)
Figure 44. Mylan N.V. Revenue Growth Rate in Myocarditis Treatment and Diagnosis Business (2017-2022)
Figure 45. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Myocarditis Treatment and Diagnosis Business (2017-2022)
Figure 46. Pfizer Inc. Revenue Growth Rate in Myocarditis Treatment and Diagnosis Business (2017-2022)
Figure 47. GlaxoSmithKline plc Revenue Growth Rate in Myocarditis Treatment and Diagnosis Business (2017-2022)
Figure 48. Novartis AG Revenue Growth Rate in Myocarditis Treatment and Diagnosis Business (2017-2022)
Figure 49. Johnson & Johnson Revenue Growth Rate in Myocarditis Treatment and Diagnosis Business (2017-2022)
Figure 50. Bayer AG Revenue Growth Rate in Myocarditis Treatment and Diagnosis Business (2017-2022)
Figure 51. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Myocarditis Treatment and Diagnosis Business (2017-2022)
Figure 52. Merck & Co., Inc. Revenue Growth Rate in Myocarditis Treatment and Diagnosis Business (2017-2022)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Keyplayers in Global Myocarditis Treatment and Diagnosis Market Research Report 2022
F. Hoffmann-La Roche Ltd.Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Johnson & Johnson
Bayer AG
Sun Pharmaceutical Industries Ltd.
Merck & Co., Inc.
